In CLL, in which ZNF224 confers apoptosis resistance, the fludarabine treatment was shown to suppress ZNF224 expression, thus increasing apoptosis rates in CLL cell lines [146]. The gene discussed is ZNF224; the disease is B-cell chronic lymphocytic leukemia.